IP Library Granted Patent US 9,546,400
Granted Patent B2
US 9,546,400 · App. 14/026,906 · Granted Jan 17, 2017

Nanopore sequencing using n-mers

Inventors: Stephen Turner (Kirkland, WA); Benjamin Flusberg (Atlanta, GA)
Assignee: Pacific Biosciences of California, Inc.
C12Q1/6874C12Q1/6869G01N27/447G01N27/44791G01N33/48721
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,546,400
App. No.
14/026,906
Granted
Jan 17, 2017
Kind
B2
Abstract

The invention relates to devices and methods for nanopore sequencing. The invention provides for using the signals from n-mers to provide sequence information, for example where the system has less than single base resolution. The invention includes arrays of nanopores having incorporated electronic circuits, for example, in CMOS. In some cases, the arrays of nanopores comprise resistive openings for isolating the electronic signals for improved sequencing. Methods for controlling translocation of through the nanopore are disclosed.

Claims (19)

1. A method for sequencing a nucleic acid template comprising:

a) providing a substrate comprising a nanopore in contact with a solution, the solution comprising a template nucleic acid above the nanopore;

b) providing a voltage across the nanopore;

c) measuring a property which has a value that varies for N monomeric units of the template nucleic acid in the pore, wherein the measuring is performed as a function of time, while the template nucleic acid is translocating through the nanopore, wherein N is three or greater; and

d) determining the sequence of the template nucleic acid using the measured property from step (c) by performing a process including comparing the measured property from step (c) to calibration information produced by measuring such property for 4 to the N sequence combinations.

2. The method of claim 1 wherein a property in step (c) comprises current.

3. The method of claim 1 wherein the translocation through the pore is driven by the applied voltage.

4. The method of claim 1 wherein the translocation rate through the pore is enzymatically controlled.

5. The method of claim 3 wherein the translocation through the pore is controlled by a polymerase, a helicase, a translocase, a viral genome packaging motor, or a chromatin remodeling complex.

6. The method of claim 1 wherein N corresponds to n-mers comprising 3-mers, 4-mers or 5-mers.

7. The method of claim 6 wherein N corresponds to n-mers comprising 3-mers.

8. The method of claim 1 wherein the method is carried out on an array of nanopores in the substrate.

9. The method of claim 1 wherein the sequencing comprises peak finding by heuristic decision-tree algorithms, Bayesian networks, hidden Markov models, or conditional random fields.

10. The method of claim 1 wherein the comparing process comprises examining a lookup table for each of the 4 to the N combinations, and keeping only those meeting a threshold value.

11. The method of claim 10 wherein threshold value is within 2 sigma of the expected value.

12. The method of claim 1 wherein some of the values for the 4 to the N sequence combinations are degenerate within the error of the measurement.

13. The method of claim 1 wherein after each single-nucleotide translocation through the nanopore, the possible n-mers for that measurement are looked up, and all the possibilities from the previous measurement that are not consistent with the most recent measurement are thrown away.

14. The method of claim 1 wherein N corresponds to n-mers comprising 4-mers.

15. The method of claim 1 wherein N corresponds to n-mers comprising 5-mers.

Continuity (3)
Continuation 12757789 · Apr 9, 2010
Provisional Application 61168431 · Apr 10, 2009
Related Publication 20140061048A1 · Mar 6, 2014